Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Transient Appearance of Plasmablasts in the Peripheral Blood of Japanese Patients with Severe Fever with Thrombocytopenia Syndrome.

Takahashi T, Suzuki T, Hiroshige S, Nouno S, Matsumura T, Tominaga T, Yujiri T, Katano H, Sato Y, Hasegawa H.

J Infect Dis. 2019 Feb 4. doi: 10.1093/infdis/jiz054. [Epub ahead of print]

PMID:
30721983
2.

[Refractory primary immune thrombocytopenia in pregnancy requiring splenectomy and repeated intravenous immunoglobulin therapy].

Kajimura Y, Tanaka Y, Nohno S, Tanaka M, Nakamura Y, Yujiri T, Matsukuma S, Nagano H, Matsuguma C, Takahashi K, Hasegawa S, Tanizawa Y.

Rinsho Ketsueki. 2018;59(12):2574-2577. doi: 10.11406/rinketsu.59.2574. Japanese.

PMID:
30626791
3.

A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.

Akuta K, Kashiwagi H, Yujiri T, Nishiura N, Morikawa Y, Kato H, Honda S, Kanakura Y, Tomiyama Y.

J Thromb Haemost. 2019 Jan;17(1):206-219. doi: 10.1111/jth.14323. Epub 2018 Nov 29.

PMID:
30388316
4.

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.

Hatta Y, Mizuta S, Matsuo K, Ohtake S, Iwanaga M, Sugiura I, Doki N, Kanamori H, Ueda Y, Yoshida C, Dobashi N, Maeda T, Yujiri T, Monma F, Ito Y, Hayakawa F, Takeuchi J, Kiyoi H, Miyazaki Y, Naoe T.

Ann Hematol. 2018 Sep;97(9):1535-1545. doi: 10.1007/s00277-018-3323-8. Epub 2018 Apr 24.

5.

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1180-1186. doi: 10.1016/j.bbmt.2018.01.026. Epub 2018 Feb 1.

PMID:
29409882
6.

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.

Haematologica. 2018 Jun;103(6):1018-1028. doi: 10.3324/haematol.2017.174177. Epub 2017 Dec 14.

7.

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG.

Sakura T, Hayakawa F, Sugiura I, Murayama T, Imai K, Usui N, Fujisawa S, Yamauchi T, Yujiri T, Kakihana K, Ito Y, Kanamori H, Ueda Y, Miyata Y, Kurokawa M, Asou N, Ohnishi K, Ohtake S, Kobayashi Y, Matsuo K, Kiyoi H, Miyazaki Y, Naoe T.

Leukemia. 2018 Mar;32(3):626-632. doi: 10.1038/leu.2017.283. Epub 2017 Sep 15.

PMID:
28914260
8.

Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation.

Nakamura Y, Matsuguma M, Tokunaga Y, Yamamoto K, Tanaka M, Tanaka Y, Yujiri T, Tanizawa Y.

Intern Med. 2017;56(10):1199-1202. doi: 10.2169/internalmedicine.56.7808. Epub 2017 May 15.

9.

Successful treatment with intravenous cyclophosphamide for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated with myelodysplastic syndrome.

Nawata T, Kubo M, Okuda S, Omoto M, Yujiri T, Kanda T, Yano M.

Scand J Rheumatol. 2017 Nov;46(6):496-498. doi: 10.1080/03009742.2016.1253770. Epub 2016 Dec 9. No abstract available.

PMID:
27931156
10.

Corrigendum: Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Taniwaki M, Kurokawa M, Morishita S, Fukayama M, Kiyoi H, Miyazaki Y, Naoe T, Mano H.

Nat Genet. 2016 Nov 29;48(12):1591. doi: 10.1038/ng1216-1587a. No abstract available.

PMID:
27898077
11.

Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.

Ichimura T, Yoshida K, Okuno Y, Yujiri T, Nagai K, Nishi M, Shiraishi Y, Ueno H, Toki T, Chiba K, Tanaka H, Muramatsu H, Hara T, Kanno H, Kojima S, Miyano S, Ito E, Ogawa S, Ohga S.

Int J Hematol. 2017 Apr;105(4):515-520. doi: 10.1007/s12185-016-2151-7. Epub 2016 Nov 23.

PMID:
27882484
12.

High-resolution CT findings of idiopathic pneumonia syndrome after haematopoietic stem cell transplantation: based on the updated concept of idiopathic pneumonia syndrome by the American Thoracic Society in 2011.

Tanaka N, Kunihiro Y, Kobayashi T, Yujiri T, Kido S, Ueda K, Matsunaga N.

Clin Radiol. 2016 Oct;71(10):953-9. doi: 10.1016/j.crad.2016.06.109. Epub 2016 Jul 12. Review.

PMID:
27421574
13.

SIRT1 is downregulated during peripheral blood stem cell mobilization in healthy donors by granulocyte-colony stimulating factor.

Sugiyama A, Yujiri T, Tanaka M, Tanaka Y, Nakamura Y, Tanizawa Y.

Ann Hematol. 2016 Aug;95(8):1381-2. doi: 10.1007/s00277-016-2701-3. Epub 2016 May 24. No abstract available.

PMID:
27220637
14.

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Taniwaki M, Kurokawa M, Morishita S, Fukayama M, Kiyoi H, Miyazaki Y, Naoe T, Mano H.

Nat Genet. 2016 May;48(5):569-74. doi: 10.1038/ng.3535. Epub 2016 Mar 28. Erratum in: Nat Genet. 2016 Nov 29;48(12 ):1591.

PMID:
27019113
15.

Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.

Nakamura Y, Tanaka Y, Tanaka M, Sugiyama A, Yamamoto K, Tokunaga Y, Yujiri T, Tanizawa Y.

Int J Hematol. 2016 Apr;103(4):436-43. doi: 10.1007/s12185-016-1936-z. Epub 2016 Jan 20.

PMID:
26791380
16.

Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.

Itonaga H, Iwanaga M, Aoki K, Aoki J, Ishiyama K, Ishikawa T, Sakura T, Fukuda T, Najima Y, Yujiri T, Mori T, Kurokawa M, Nawa Y, Uchida N, Morishita Y, Hashimoto H, Eto T, Hirokawa M, Morishima Y, Nagamura-Inoue T, Atsuta Y, Miyazaki Y.

Leuk Res. 2016 Feb;41:48-55. doi: 10.1016/j.leukres.2015.12.009. Epub 2015 Dec 24.

PMID:
26754557
17.

Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT.

Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J.

Bone Marrow Transplant. 2016 Jan;51(1):43-50. doi: 10.1038/bmt.2015.217. Epub 2015 Sep 21.

PMID:
26389833
18.

Altered expression of circadian clock genes during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor.

Sugiyama A, Yujiri T, Tanaka M, Tanaka Y, Nakamura Y, Tanizawa Y.

Chronobiol Int. 2015;32(7):934-41. doi: 10.3109/07420528.2015.1053910.

PMID:
26158633
19.

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.

Hayakawa F, Sakura T, Yujiri T, Kondo E, Fujimaki K, Sasaki O, Miyatake J, Handa H, Ueda Y, Aoyama Y, Takada S, Tanaka Y, Usui N, Miyawaki S, Suenobu S, Horibe K, Kiyoi H, Ohnishi K, Miyazaki Y, Ohtake S, Kobayashi Y, Matsuo K, Naoe T; Japan Adult Leukemia Study Group (JALSG).

Blood Cancer J. 2014 Oct 17;4:e252. doi: 10.1038/bcj.2014.72.

20.

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance.

Yujiri T, Nakamura Y, Oota I, Nakano K, Tanizawa Y.

Ann Hematol. 2014 Aug;93(8):1427-8. doi: 10.1007/s00277-013-1982-z. Epub 2013 Dec 11. No abstract available.

PMID:
24337448
21.

Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J.

Bone Marrow Transplant. 2013 Nov;48(12):1513-8. doi: 10.1038/bmt.2013.140. Epub 2013 Sep 23. Erratum in: Bone Marrow Transplant. 2013 Nov;48(12):1587.

PMID:
24056740
22.

Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation.

Nakamura Y, Mitani N, Ishii A, Hayashi S, Yujiri T, Ikeda E, Tanizawa Y.

Int J Hematol. 2013 Oct;98(4):496-8. doi: 10.1007/s12185-013-1413-x. Epub 2013 Aug 17.

PMID:
23955112
23.

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide.

Yujiri T, Tanaka M, Taguchi A, Tanaka Y, Nakamura Y, Tanizawa Y.

Ann Hematol. 2014 Feb;93(2):351-2. doi: 10.1007/s00277-013-1804-3. Epub 2013 Jun 1. No abstract available.

PMID:
23728611
24.

A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.

Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S, Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transpl Int. 2013 Jun;26(6):631-9. doi: 10.1111/tri.12093. Epub 2013 Apr 1.

25.

JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients.

Tanaka M, Yujiri T, Ito S, Okayama N, Takahashi T, Shinohara K, Azuno Y, Nawata R, Hinoda Y, Tanizawa Y.

Int J Hematol. 2013 Mar;97(3):409-13. doi: 10.1007/s12185-013-1295-y. Epub 2013 Feb 22.

PMID:
23430670
26.

Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL.

Mizuta S, Matsuo K, Maeda T, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Takada S, Yokota A, Takatsuka Y, Tamaki S, Imai K, Moriuchi Y, Miyazaki Y, Ohtake S, Ohnishi K, Naoe T.

Blood Cancer J. 2012 May;2(5):e72. doi: 10.1038/bcj.2012.18. Epub 2012 May 18.

27.

Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF.

Tanaka M, Yujiri T, Tanaka Y, Mitani N, Tanimura A, Tanizawa Y.

Bone Marrow Transplant. 2012 Aug;47(8):1143-4. doi: 10.1038/bmt.2011.233. Epub 2011 Nov 28. No abstract available.

PMID:
22120987
28.

Activation of the unfolded protein response in primary acute myeloid leukemia cells.

Tanimura A, Yujiri T, Tanaka Y, Tanaka M, Mitani N, Nakamura Y, Ariyoshi K, Tanizawa Y.

Int J Hematol. 2011 Sep;94(3):300-302. doi: 10.1007/s12185-011-0918-4. Epub 2011 Aug 24. No abstract available.

PMID:
21863285
29.

Hematopoietic progenitor cell count, but not immature platelet fraction value, predicts successful harvest of autologous peripheral blood stem cells.

Mitani N, Yujiri T, Tanaka Y, Tanaka M, Fujii Y, Hinoda Y, Tanizawa Y.

J Clin Apher. 2011;26(3):105-10. doi: 10.1002/jca.20275. Epub 2010 Dec 6.

PMID:
21647950
30.

High-resolution computed tomography of chest complications in patients treated with hematopoietic stem cell transplantation.

Tanaka N, Kunihiro Y, Yujiri T, Ando T, Gondo T, Kido S, Matsunaga N.

Jpn J Radiol. 2011 May;29(4):229-35. doi: 10.1007/s11604-010-0544-8. Epub 2011 May 24. Review.

PMID:
21607835
31.

Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.

Iida M, Fukuda T, Ikegame K, Yoshihara S, Ogawa H, Taniguchi S, Takami A, Abe Y, Hino M, Etou T, Ueda Y, Yujiri T, Matsui T, Okamura A, Tanaka J, Atsuta Y, Kodera Y, Suzuki R.

Int J Hematol. 2011 Apr;93(4):523-531. doi: 10.1007/s12185-011-0817-8. Epub 2011 Apr 5.

PMID:
21465117
32.

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab.

Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima AM, Niitsu N, Ennishi D, Tamaru JI, Ishizawa K, Kashimura M, Kagami Y, Sunami K, Yamane H, Nishikori M, Kosugi H, Yujiri T, Hyo R, Katayama N, Kinoshita T, Nakamura S.

Ann Oncol. 2011 Jul;22(7):1601-7. doi: 10.1093/annonc/mdq627. Epub 2011 Jan 3.

PMID:
21199885
33.

F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.

Suga K, Yasuhiko K, Matsunaga N, Yujiri T, Nakazora T, Ariyoshi K.

Clin Nucl Med. 2011 Jan;36(1):73-6. doi: 10.1097/RLU.0b013e3181f4a03f.

PMID:
21157220
34.

Engraftment syndrome after hematopoietic stem cell transplantation: high-resolution computed tomography findings in 2 patients.

Kunihiro Y, Tanaka N, Ando T, Yujiri T, Matsunaga N.

J Thorac Imaging. 2011 Feb;26(1):W23-5. doi: 10.1097/RTI.0b013e3181f240e0.

PMID:
21042224
35.

Alteration in serum B cell-activating factor levels inpatients with idiopathic thrombocytopenic purpura after Helicobacter pylori eradication therapy.

Yujiri T, Tanaka Y, Tanaka M, Takahashi T, Tanizawa Y.

Br J Haematol. 2011 Feb;152(4):496-8. doi: 10.1111/j.1365-2141.2010.08403.x. Epub 2010 Oct 19. No abstract available.

PMID:
20955408
36.

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.

Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Miyazaki Y, Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T, Ohno R.

Leukemia. 2011 Jan;25(1):41-7. doi: 10.1038/leu.2010.228. Epub 2010 Oct 14.

PMID:
20944676
37.

Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor.

Asakura M, Ikegame K, Yoshihara S, Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H.

Int J Hematol. 2010 Sep;92(2):351-9. doi: 10.1007/s12185-010-0657-y. Epub 2010 Aug 7.

PMID:
20694532
38.

Increased serum levels of high-mobility group box 1 protein in patients who developed acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Yujiri T, Tagami K, Tanaka Y, Mitani N, Nakamura Y, Ariyoshi K, Ando T, Tanizawa Y.

Eur J Haematol. 2010 Oct;85(4):366-7. doi: 10.1111/j.1600-0609.2010.01507.x. Epub 2010 Aug 30. No abstract available.

PMID:
20659154
39.

Cytomegalovirus ventriculoencephalitis in a reduced- intensity conditioning cord blood transplant recipient.

Ando T, Mitani N, Yamashita K, Takahashi T, Ohama E, Miyata H, Yujiri T, Tanizawa Y.

Transpl Infect Dis. 2010 Oct;12(5):441-5. doi: 10.1111/j.1399-3062.2010.00503.x.

PMID:
20487415
40.

Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.

Ando T, Mitani N, Matsunaga K, Nakazora T, Gondo T, Yujiri T, Tanizawa Y.

Tohoku J Exp Med. 2010 Feb;220(2):121-6.

41.

Alteration of adipokines during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor.

Tanaka Y, Yujiri T, Tanaka M, Mitani N, Tanimura A, Tanizawa Y.

J Clin Apher. 2009;24(5):205-8. doi: 10.1002/jca.20212.

PMID:
19816958
42.

Fluctuations in thrombopoietin, immature platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia.

Yujiri T, Tanaka Y, Tanaka M, Tanizawa Y.

Int J Hematol. 2009 Oct;90(3):429-430. doi: 10.1007/s12185-009-0415-1. Epub 2009 Aug 29. No abstract available.

PMID:
19728020
43.

Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity.

Ando T, Mitani N, Matsui K, Yamashita K, Nomiyama J, Tsuru M, Yujiri T, Tanizawa Y.

Int J Hematol. 2009 Oct;90(3):374-377. doi: 10.1007/s12185-009-0385-3. Epub 2009 Jul 24.

PMID:
19629629
44.

Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.

Tagami K, Yujiri T, Takahashi T, Kizuki N, Tanaka Y, Mitani N, Nakamura Y, Ariyoshi K, Ando T, Gondo T, Tanizawa Y.

Int J Hematol. 2009 Sep;90(2):248-252. doi: 10.1007/s12185-009-0358-6. Epub 2009 Jun 23.

PMID:
19548069
45.

TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J.

PLoS One. 2009 May 25;4(5):e5674. doi: 10.1371/journal.pone.0005674.

46.

The anti-apoptotic role of the unfolded protein response in Bcr-Abl-positive leukemia cells.

Tanimura A, Yujiri T, Tanaka Y, Hatanaka M, Mitani N, Nakamura Y, Mori K, Tanizawa Y.

Leuk Res. 2009 Jul;33(7):924-8. doi: 10.1016/j.leukres.2009.01.027. Epub 2009 Feb 23.

PMID:
19237191
47.

A novel t(11;14)(q23;q32) in a case of myelodysplastic syndrome.

Yujiri T, Miyazaki M, Imoto S.

Cancer Genet Cytogenet. 2009 Jan 15;188(2):124-5. doi: 10.1016/j.cancergencyto.2008.09.014. No abstract available.

PMID:
19100518
48.

Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.

Yanada M, Sugiura I, Takeuchi J, Akiyama H, Maruta A, Ueda Y, Usui N, Yagasaki F, Yujiri T, Takeuchi M, Nishii K, Kimura Y, Miyawaki S, Narimatsu H, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.

Br J Haematol. 2008 Nov;143(4):503-10. doi: 10.1111/j.1365-2141.2008.07377.x.

PMID:
18986386
49.

Allogeneic peripheral blood stem cell transplantation from related donors mismatched at 2 HLA loci in the host-versus-graft direction.

Ando T, Yujiri T, Nomiyama J, Mitani N, Seguchi M, Matsubara A, Tanizawa Y.

Tohoku J Exp Med. 2008 Feb;214(2):159-63.

50.

Successful engraftment of the second reduced-intensity conditioning cord blood transplantation (CBT) for a patient who developed graft rejection and infectious complications after the first CBT for AML.

Nakamura Y, Tanaka Y, Ando T, Sato Y, Yujiri T, Tanizawa Y.

Bone Marrow Transplant. 2007 Aug;40(4):395-6. Epub 2007 Jun 18. No abstract available.

PMID:
17572713

Supplemental Content

Loading ...
Support Center